Year To Quarter End Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7585095

Concept 2022-04-01 to
2022-09-30
2021-04-01 to
2021-09-30
Year to quarter end statement of income
Statement of income
Net sales
179,000 JPY
263,000 JPY
Cost of sales
44,000 JPY
65,000 JPY
Gross profit (loss)
134,000 JPY
197,000 JPY
Selling, general and administrative expenses
805,202,000 JPY
721,668,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
-805,068,000 JPY
-721,471,000 JPY
Non-operating income
Interest income
11,000 JPY
14,000 JPY
Non-operating income
557,000 JPY
59,000 JPY
Non-operating expenses
Non-operating expenses
5,281,000 JPY
2,049,000 JPY
Ordinary profit (loss)
-809,792,000 JPY
-723,461,000 JPY
Extraordinary income
Extraordinary income
JPY
4,455,000 JPY
Extraordinary losses
Impairment losses
JPY
3,667,000 JPY
Extraordinary losses
JPY
3,704,000 JPY
Profit (loss) before income taxes
-809,792,000 JPY
-722,710,000 JPY
Income taxes - current
950,000 JPY
1,210,000 JPY
Income taxes
950,000 JPY
1,210,000 JPY
Profit (loss)
-810,742,000 JPY
-723,920,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.